Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histamine N-methyltransferase (HNMT) is an enzyme that catalyzes the methylation of histamine, inactivating it. It transfers a methyl group from S-adenosyl-L-methionine (SAM) to histamine, producing Nτ-methylhistamine. This is a major histamine inactivation pathway, particularly in the central nervous system. HNMT plays a critical role in modulating allergic reactions, neurotransmission, gastric acid secretion, and other histamine-related processes. Alterations in HNMT function can affect susceptibility to allergic diseases.
Inhibition of histamine N-methylation
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histamine N-methyltransferase (HNMT).